Simple strategies to develop your digital health vision.
Healthcare businesses will experience seismic shifts as consumers take ownership of their data.
Specialty drugs represent an opportunity to better serve patients, but also pose risks.
The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.
The healthcare industry is finally coming to terms with the fact that disruption is here.
Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.
Oliver Wyman has partnered with venture capitalist firms and senior leaders to support those in pursuit of health transformation.
Healthcare systems know M&A, cost transformation, and SDOH can reap big rewards. Bold models will thrive.
A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.